David A. Maine, Co-Founder and CFO oversees the business operations of Strykagen’s suite of therapeutic products for the treatment of the muscular dystrophies. With more than 15 years of managerial experience, Mr. Maine is involved in the commercialization of Strykagen’s technologies. Mr. Maine has experience with Federal grants contracts, governmental accounting practices, community relations, economic development, market research, business planning, and policy analysis.

David received his BS in Environmental Resource Economics and his MA in Economics from the College of Business in 2015 at the University of Nevada, Reno. Mr. Maine is involved in the commercialization of technologies developed by researchers at UNR.